Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from JB Chemicals & Pharmaceuticals Ltd. ( (IN:JBCHEPHARM) ).
JB Chemicals & Pharmaceuticals has launched a postal ballot process seeking shareholder approval for several board appointments, including elevating Aman Mehta to director and managing director. The exercise also covers the induction of Amal Kelshikar, Hasmukh Patel and Sudhir Menon as non-executive, non-independent directors, with voting conducted exclusively via remote e-voting between February 22 and March 23, 2026.
The move signals a significant refresh of the company’s top leadership and board composition, which could influence its strategic direction and corporate governance framework. By relying solely on electronic voting and adhering to updated SEBI and MCA guidelines, the company underscores its compliance focus and aims to ensure broader, more efficient participation from its dispersed shareholder base.
More about JB Chemicals & Pharmaceuticals Ltd.
JB Chemicals & Pharmaceuticals Ltd. is an Indian pharmaceutical manufacturer focused on branded formulations and over-the-counter products, with a presence in domestic and international markets. The company operates in regulated markets and supplies a range of prescription and specialty medicines, positioning itself as a mid-sized player in the healthcare and pharma sector.
Average Trading Volume: 9,283
Technical Sentiment Signal: Buy
Current Market Cap: 318.4B INR
Learn more about JBCHEPHARM stock on TipRanks’ Stock Analysis page.